<script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app39.us.archive.org';v.server_ms=558;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include --><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<script type="text/javascript" src="/static/js/timestamp.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/graph-calc.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/auto-complete.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/toolbar.js?v=1531166943.0" charset="utf-8"></script>

<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
.wb-autocomplete-suggestions {
    text-align: left; cursor: default; border: 1px solid #ccc; border-top: 0; background: #fff; box-shadow: -1px 1px 3px rgba(0,0,0,.1);
    position: absolute; display: none; z-index: 2147483647; max-height: 254px; overflow: hidden; overflow-y: auto; box-sizing: border-box;
}
.wb-autocomplete-suggestion { position: relative; padding: 0 .6em; line-height: 23px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; font-size: 1.02em; color: #333; }
.wb-autocomplete-suggestion b { font-weight: bold; }
.wb-autocomplete-suggestion.selected { background: #f0f0f0; }
</style>
<div id="wm-ipp" lang="en" style="display:none;direction:ltr;">
<div style="position:fixed;left:0;top:0;right:0;">
<div id="wm-ipp-inside">
  <div style="position:relative;">
    <div id="wm-logo" style="float:left;width:130px;padding-top:10px;">
      <a href="/web/" title="Wayback Machine home page"><img src="/static/images/toolbar/wayback-toolbar-logo.png" alt="Wayback Machine" width="110" height="39" border="0" /></a>
    </div>
    <div class="r" style="float:right;">
      <div id="wm-btns" style="text-align:right;height:25px;">
                  <div id="wm-save-snapshot-success">success</div>
          <div id="wm-save-snapshot-fail">fail</div>
          <a href="#"
             onclick="__wm.saveSnapshot('https://www.guideline.gov/summaries/downloadcontent/ngc-11295?contentType=xml', '20180712194256')"
             title="Share via My Web Archive"
             id="wm-save-snapshot-open"
          >
            <span class="iconochive-web"></span>
          </a>
          <a href="https://archive.org/account/login.php"
             title="Sign In"
             id="wm-sign-in"
          >
            <span class="iconochive-person"></span>
          </a>
          <span id="wm-save-snapshot-in-progress" class="iconochive-web"></span>
        	<a href="http://faq.web.archive.org/" title="Get some help using the Wayback Machine" style="top:-6px;"><span class="iconochive-question" style="color:rgb(87,186,244);font-size:160%;"></span></a>
	<a id="wm-tb-close" href="#close" onclick="__wm.h(event);return false;" style="top:-2px;" title="Close the toolbar"><span class="iconochive-remove-circle" style="color:#888888;font-size:240%;"></span></a>
      </div>
      <div id="wm-share" style="text-align:right;">
	<a href="#" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=https://web.archive.org/web/20180712194256/https://www.guideline.gov/summaries/downloadcontent/ngc-11295?contentType=xml', '', 'height=400,width=600'); return false;" title="Share on Facebook" style="margin-right:5px;" target="_blank"><span class="iconochive-facebook" style="color:#3b5998;font-size:160%;"></span></a>
	<a href="#" onclick="window.open('https://twitter.com/intent/tweet?text=https://web.archive.org/web/20180712194256/https://www.guideline.gov/summaries/downloadcontent/ngc-11295?contentType=xml&amp;via=internetarchive', '', 'height=400,width=600'); return false;" title="Share on Twitter" style="margin-right:5px;" target="_blank"><span class="iconochive-twitter" style="color:#1dcaff;font-size:160%;"></span></a>
      </div>
    </div>
    <table class="c" style="">
      <tbody>
	<tr>
	  <td class="u" colspan="2">
	    <form target="_top" method="get" action="/web/submit" name="wmtb" id="wmtb"><input type="text" name="url" id="wmtbURL" value="https://www.guideline.gov/summaries/downloadcontent/ngc-11295?contentType=xml" onfocus="this.focus();this.select();" /><input type="hidden" name="type" value="replay" /><input type="hidden" name="date" value="20180712194256" /><input type="submit" value="Go" /></form>
	  </td>
	  <td class="n" rowspan="2" style="width:110px;">
	    <table>
	      <tbody>
		<!-- NEXT/PREV MONTH NAV AND MONTH INDICATOR -->
		<tr class="m">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20180610042512/https://www.guideline.gov/summaries/downloadcontent/ngc-11295?contentType=xml" title="10 Jun 2018"><strong>Jun</strong></a></td>
		  <td class="c" id="displayMonthEl" title="You are here: 19:42:56 Jul 12, 2018">JUL</td>
		  <td class="f" nowrap="nowrap">Aug</td>
		</tr>
		<!-- NEXT/PREV CAPTURE NAV AND DAY OF MONTH INDICATOR -->
		<tr class="d">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20180610042512/https://www.guideline.gov/summaries/downloadcontent/ngc-11295?contentType=xml" title="04:25:12 Jun 10, 2018"><img src="/static/images/toolbar/wm_tb_prv_on.png" alt="Previous capture" width="14" height="16" border="0" /></a></td>
		  <td class="c" id="displayDayEl" style="width:34px;font-size:24px;white-space:nowrap;" title="You are here: 19:42:56 Jul 12, 2018">12</td>
		  <td class="f" nowrap="nowrap"><img src="/static/images/toolbar/wm_tb_nxt_off.png" alt="Next capture" width="14" height="16" border="0" /></td>
		</tr>
		<!-- NEXT/PREV YEAR NAV AND YEAR INDICATOR -->
		<tr class="y">
		  <td class="b" nowrap="nowrap">2017</td>
		  <td class="c" id="displayYearEl" title="You are here: 19:42:56 Jul 12, 2018">2018</td>
		  <td class="f" nowrap="nowrap">2019</td>
		</tr>
	      </tbody>
	    </table>
	  </td>
	</tr>
	<tr>
	  <td class="s">
	    	    <div id="wm-nav-captures">
	      	      <a class="t" href="/web/20180712194256*/https://www.guideline.gov/summaries/downloadcontent/ngc-11295?contentType=xml" title="See a list of every capture for this URL">3 captures</a>
	      <div class="r" title="Timespan for captures of this URL">19 May 2018 - 12 Jul 2018</div>
	      </div>
	  </td>
	  <td class="k">
	    <a href="" id="wm-graph-anchor">
	      <div id="wm-ipp-sparkline" title="Explore captures for this URL" style="position: relative">
		<canvas id="wm-sparkline-canvas" width="575" height="27" border="0"></canvas>
	      </div>
	    </a>
	  </td>
	</tr>
      </tbody>
    </table>
    <div style="position:absolute;bottom:0;right:2px;text-align:right;">
      <a id="wm-expand" class="wm-btn wm-closed" href="#expand" onclick="__wm.ex(event);return false;"><span id="wm-expand-icon" class="iconochive-down-solid"></span> <span style="font-size:80%">About this capture</span></a>
    </div>
  </div>
    <div id="wm-capinfo" style="border-top:1px solid #777;display:none; overflow: hidden">
            <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center">COLLECTED BY</div>
    <div style="padding:3px;position:relative" id="wm-collected-by-content">
            <div style="display:inline-block;vertical-align:top;width:50%;">
			<span class="c-logo" style="background-image:url(https://archive.org/services/img/archiveteam);"></span>
		Organization: <a style="color:#33f;" href="https://archive.org/details/archiveteam" target="_new"><span class="wm-title">Archive Team</span></a>
		<div style="max-height:75px;overflow:hidden;position:relative;">
	  <div style="position:absolute;top:0;left:0;width:100%;height:75px;background:linear-gradient(to bottom,rgba(255,255,255,0) 0%,rgba(255,255,255,0) 90%,rgba(255,255,255,255) 100%);"></div>
	  <img align=right src="http://archiveteam.org/images/e/e6/Archiveteam.jpg" width=200> Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed of volunteers and interested parties, and has expanded into a large amount of related projects for saving online and digital history.
<p>
History is littered with hundreds of conflicts over the future of a community, group, location or business that were "resolved" when one of the parties stepped ahead and destroyed what was there. With the original point of contention destroyed, the debates would fall to the wayside. Archive Team believes that by duplicated condemned data, the conversation and debate can continue, as well as the richness and insight gained by keeping the materials. Our projects have ranged in size from a single volunteer downloading the data to a small-but-critical site, to over 100 volunteers stepping forward to acquire terabytes of user-created data to save for future generations.
<p>
The main site for Archive Team is at <a href="http://www.archiveteam.org">archiveteam.org</a> and contains up to the date information on various projects, manifestos, plans and walkthroughs.
<p>
This collection contains the output of many Archive Team projects, both ongoing and completed. Thanks to the generous providing of disk space by the Internet Archive, multi-terabyte datasets can be made available, as well as in use by the <a href="http://archive.org/web/web.php">Wayback Machine</a>, providing a path back to lost websites and work. 
<p>
Our collection has grown to the point of having sub-collections for the type of data we acquire. If you are seeking to browse the contents of these collections, the Wayback Machine is the best first stop. Otherwise, you are free to dig into the stacks to see what you may find.
<p>
<b>The Archive Team Panic Downloads</b> are full pulldowns of currently extant websites, meant to serve as emergency backups for needed sites that are in danger of closing, or which will be missed dearly if suddenly lost due to hard drive crashes or server failures. 
<p>
	</div>
	      </div>
      <div style="display:inline-block;vertical-align:top;width:49%;">
			<span class="c-logo" style="background-image:url(https://archive.org/services/img/archivebot)"></span>
		<div>Collection: <a style="color:#33f;" href="https://archive.org/details/archivebot" target="_new"><span class="wm-title">ArchiveBot: The Archive Team Crowdsourced Crawler</span></a></div>
		<div style="max-height:75px;overflow:hidden;position:relative;">
	  <div style="position:absolute;top:0;left:0;width:100%;height:75px;background:linear-gradient(to bottom,rgba(255,255,255,0) 0%,rgba(255,255,255,0) 90%,rgba(255,255,255,255) 100%);"></div>
	  ArchiveBot is an IRC bot designed to automate the archival of smaller websites (e.g. up to a few hundred thousand URLs). You give it a URL to start at, and it grabs all content under that URL, records it in a WARC, and then uploads that WARC to ArchiveTeam servers for eventual injection into the Internet Archive (or other archive sites).
<p>
To use ArchiveBot, drop by #archivebot on EFNet. To interact with ArchiveBot, you issue commands by typing it into the channel. Note you will need channel operator permissions in order to issue archiving jobs. The dashboard shows the sites being downloaded currently.
<p>
There is a dashboard running for the archivebot process at <a href="http://www.archivebot.com">http://www.archivebot.com</a>.
<p>
ArchiveBot's source code can be found at <a href="https://github.com/ArchiveTeam/ArchiveBot">https://github.com/ArchiveTeam/ArchiveBot</a>.
	</div>
	      </div>
    </div>
    <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center" title="Timestamps for the elements of this page">TIMESTAMPS</div>
    <div>
      <div id="wm-capresources" style="margin:0 5px 5px 5px;max-height:250px;overflow-y:scroll !important"></div>
      <div id="wm-capresources-loading" style="text-align:left;margin:0 20px 5px 5px;display:none"><img src="/static/images/loading.gif" alt="loading" /></div>
    </div>
  </div></div></div></div><script type="text/javascript">
__wm.bt(575,27,25,2,"web","https://www.guideline.gov/summaries/downloadcontent/ngc-11295?contentType=xml","2018-07-12",1996);
</script>
<!-- END WAYBACK TOOLBAR INSERT --><version>
  <xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource>
  <section secid="390" ordby="100" name="General">
    <field fieldid="161" ordby="105" id="391" name="Guideline Title" type="text">
      <fieldvalue value="<div class=&quot;content_title&quot;>Clinical policy: emergency department management of patients needing reperfusion therapy for acute ST-segment elevation myocardial infarction.</div>"/>
    </field>
    <field fieldid="97" ordby="110" id="392" name="Bibliographic Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>Promes SB, Glauser JM, Smith MD, Torbati SS, Brown MD, American College of Emergency Physicians. Clinical policy: emergency department management of patients needing reperfusion therapy for acute ST-segment elevation myocardial infarction. Ann Emerg Med. 2017 Nov;70(5):724-39. [28 references] <a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=29056206 &quot; target=&quot;_blank&quot;>PubMed</a></td></tr></table>"/>
    </field>
    <field fieldid="120" ordby="115" id="393" name="Guideline Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Fesmire FM, Brady WJ, Hahn S, Decker WW, Diercks DB, Ghaemmaghami CA, Nazarian D, Jagoda AS, American College of Emergency Physicians Clinical Policies Subcommittee. Clinical policy: indications for reperfusion therapy in emergency department patients with suspected acute myocardial infarction. Ann Emerg Med. 2006 Oct;48(4):358-83. [86 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div>"/>
    </field>
  </section>
  <section secid="705" ordby="150" name="NEATS Assessment">
    <field fieldid="183" ordby="10" id="706" name="Disclosure of Guideline Funding Source" type="picklist-one">
      <fieldvalue value="Yes"/>
    </field>
    <field fieldid="184" ordby="20" id="707" name="Disclosure and Management of Financial Conflict of Interests" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="185" ordby="30" id="708" name="Guideline Development Group Composition: Multidisciplinary Group" type="picklist-one">
      <fieldvalue value="Unknown"/>
    </field>
    <field fieldid="186" ordby="40" id="709" name="Guideline Development Group Composition: Methodologist Involvement" type="picklist-one">
      <fieldvalue value="Yes"/>
    </field>
    <field fieldid="187" ordby="50" id="710" name="Guideline Development Group Composition: Patient and Public Perspectives" type="picklist-one">
      <fieldvalue value="2"/>
    </field>
    <field fieldid="188" ordby="60" id="711" name="Use of a Systematic Review of Evidence: Search Strategy" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="189" ordby="70" id="712" name="Use of a Systematic Review of Evidence: Study Selection" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="190" ordby="80" id="713" name="Use of a Systematic Review of Evidence: Synthesis of Evidence" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="191" ordby="90" id="714" name="Evidence Foundations for and Rating Strength of Recommendations: Grading the Quality or Strength of Evidence" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="192" ordby="100" id="715" name="Evidence Foundations for and Rating Strength of Recommendations: Benefits and Harms of Recommendations" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="193" ordby="110" id="716" name="Evidence Foundations for and Rating Strength of Recommendations: Evidence Summary Supporting Recommendations" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="194" ordby="120" id="717" name="Evidence Foundations for and Rating Strength of Recommendations: Rating the Strength of Recommendations" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="195" ordby="130" id="718" name="Specific and Unambiguous Articulation of Recommendations" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="196" ordby="140" id="719" name="External Review" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="197" ordby="150" id="720" name="Updating" type="picklist-one">
      <fieldvalue value="3"/>
    </field>
  </section>
  <section secid="420" ordby="300" name="Recommendations">
    <field fieldid="151" ordby="310" id="421" name="Major Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Definitions for the class of evidence (<strong>Class I-III</strong>) and level of recommendations (<strong>A-C</strong>) are provided at the end of the &quot;Major Recommendations&quot; field.</p>
<ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;>
    <li><strong>In adult patients having an ST-segment elevation myocardial infarction (STEMI), are there patients for whom treatment with fibrinolytic therapy decreases the incidence of major adverse cardiac events (MACE) when percutaneous coronary intervention (PCI) is delayed?</strong>
    <p><strong><em>Level A recommendations</em></strong>. None specified.</p>
    <p><strong><em>Level B recommendations</em></strong>. Fibrinolytics may be administered to patients when door-to-balloon (D2B) time is anticipated to exceed 120 minutes.</p>
    <p><strong><em>Level C recommendations</em></strong>. A dose reduction should be considered when administering fibrinolytics to patients aged 75 years or older.</p>
    </li>
    <li><strong>In adult patients having a STEMI, does transfer to a PCI center decrease the incidence of MACE?</strong>
    <p><strong><em>Level A recommendations</em></strong>. None specified.</p>
    <p><strong><em>Level B recommendations</em></strong>. To decrease the incidence of MACE, patients with STEMI should be transferred to a PCI-capable hospital as soon as possible.</p>
    <p><strong><em>Level C recommendations</em></strong>. None specified.</p>
    </li>
    <li><strong>In adult patients undergoing reperfusion therapy, should opioids be avoided to prevent adverse outcomes?</strong>
    <p><strong><em>Level A recommendations</em></strong>. None specified.</p>
    <p><strong><em>Level B recommendations</em></strong>. None specified.</p>
    <p><strong><em>Level C recommendations</em></strong>. Because safety has not been established, clinical judgment should be used in deciding whether to provide or withhold morphine in patients undergoing reperfusion therapy.</p>
    </li>
</ol>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Definitions</span></strong></p>
<p><strong>Class of Evidence</strong></p>
<p><em>Literature Classification Schema*</em></p>
<table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Literature Classification Schema&quot;>
    <thead>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Design/Class</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Therapy&amp;dagger;</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Diagnosis&amp;Dagger;</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Prognosis&amp;sect;</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>1</td>
            <td valign=&quot;top&quot;>Randomized controlled trial or meta-analysis of randomized trials</td>
            <td valign=&quot;top&quot;>Prospective cohort using a criterion standard or meta-analysis of prospective studies</td>
            <td valign=&quot;top&quot;>Population prospective cohort or meta-analysis of prospective studies</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>2</td>
            <td valign=&quot;top&quot;>Nonrandomized trial</td>
            <td valign=&quot;top&quot;>Retrospective observational</td>
            <td valign=&quot;top&quot;>Retrospective cohort<br />
            Case control </td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>3</td>
            <td valign=&quot;top&quot;>Case series</td>
            <td valign=&quot;top&quot;>Case series</td>
            <td valign=&quot;top&quot;>Case series</td>
        </tr>
    </tbody>
</table>
<p class=&quot;Note&quot;>*Some designs (e.g., surveys) will not fit this schema and should be assessed individually.</p>
<p class=&quot;Note&quot;><sup>&amp;dagger;</sup>Objective is to measure therapeutic efficacy comparing interventions.</p>
<p class=&quot;Note&quot;><sup>&amp;Dagger;</sup>Objective is to determine the sensitivity and specificity of diagnostic tests.</p>
<p class=&quot;Note&quot;><sup>&amp;sect;</sup>Objective is to predict outcome, including mortality and morbidity.</p>
<p><em>Approach to Downgrading Strength of Evidence*</em></p>
<table width=&quot;60%&quot; border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Approach to Downgrading Strength of Evidence&quot;>
    <thead>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; rowspan=&quot;2&quot; scope=&quot;col&quot;>Downgrading</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;3&quot; scope=&quot;col&quot;>Design/Class</th>
        </tr>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>1</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>2</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>3</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign=&quot;top&quot;>None</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>I</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>II</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>III</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>1 level</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>II</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>III</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>2 levels</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>III</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Fatally flawed</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
        </tr>
    </tbody>
</table>
<p class=&quot;Note&quot;>*See the &quot;Description of Methods Used to Analyze the Evidence&quot; field for more information.</p>
<p><strong>Translation of Class of Evidence to Recommendation Levels</strong></p>
<p>Based on the strength of evidence grading for each critical question (see the Evidentiary Table in the original guideline document), the subcommittee drafted the recommendations and the supporting text synthesizing the evidence using the following guidelines:</p>
<p><strong>Level A recommendations</strong>. Generally accepted principles for patient care that reﬂect a high degree of clinical certainty (e.g., based on evidence from 1 or more Class of Evidence I or multiple Class of Evidence II studies).</p>
<p><strong>Level B recommendations</strong>. Recommendations for patient care that may identify a particular strategy or range of strategies that reﬂect moderate clinical certainty (e.g., based on evidence from 1 or more Class of Evidence II studies or strong consensus of Class of Evidence III studies).</p>
<p><strong>Level C recommendations</strong>. Recommendations for patient care that are based on evidence from Class of Evidence III studies or, in the absence of any adequate published literature, based on expert consensus. In instances in which consensus recommendations are made, &quot;consensus&quot; is placed in parentheses at the end of the recommendation.</p>
<p>There are certain circumstances in which the recommendations stemming from a body of evidence should not be rated as highly as the individual studies on which they are based. Factors such as heterogeneity of results, uncertainty about effect magnitude and publication bias, among others, might lead to such a downgrading of recommendations.</p></div>"/>
    </field>
    <field fieldid="138" ordby="330" id="423" name="Clinical Algorithm(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>None provided</p></div>"/>
    </field>
  </section>
  <section secid="396" ordby="400" name="Scope">
    <field fieldid="140" ordby="405" id="397" name="Disease/Condition(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Acute ST-segment elevation myocardial infarction (STEMI)</p></div>"/>
    </field>
    <field fieldid="103" ordby="410" id="398" name="Guideline Category" type="picklist-many">
      <fieldvalue value="Evaluation"/>
      <fieldvalue value="Management"/>
      <fieldvalue value="Risk Assessment"/>
      <fieldvalue value="Treatment"/>
    </field>
    <field fieldid="113" ordby="415" id="399" name="Clinical Specialty" type="picklist-many">
      <fieldvalue value="Cardiology"/>
      <fieldvalue value="Emergency Medicine"/>
    </field>
    <field fieldid="114" ordby="420" id="400" name="Intended Users" type="picklist-many">
      <fieldvalue value="Health Care Providers"/>
      <fieldvalue value="Physicians"/>
    </field>
    <field fieldid="129" ordby="425" id="401" name="Guideline Objective(s)" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>To address key issues in reperfusion for patients with acute ST-segment elevation myocardial infarction (STEMI)</li>
    <li>To derive evidence-based recommendations to answer the following clinical questions:
    <ul style=&quot;list-style-type: disc;&quot;>
        <li>In adult patients having a STEMI, are there patients for whom treatment with fibrinolytic therapy decreases the incidence of major adverse cardiac events (MACE) when percutaneous coronary intervention (PCI) is delayed? </li>
        <li>In adult patients having a STEMI, does transfer to a PCI center decrease the incidence of MACE? </li>
        <li>In adult patients undergoing reperfusion therapy, should opioids be avoided to prevent adverse outcomes? </li>
    </ul>
    </li>
</ul>"/>
    </field>
    <field fieldid="132" ordby="430" id="402" name="Target Population" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Adult patients presenting to the emergency department (ED) with suspected acute ST-segment elevation myocardial infarction (STEMI)</p>
<p class=&quot;Note&quot;><strong>Note</strong>: This guideline is not intended for pediatric patients, pregnant patients, or patients with contraindications to fibrinolytic treatment.</p></div>"/>
    </field>
    <field fieldid="133" ordby="435" id="403" name="Interventions and Practices Considered" type="text">
      <fieldvalue value="<ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;>
    <li>Administration of fibrinolytics when door-to-balloon (D2B) time is anticipated to exceed 120 minutes </li>
    <li>Consideration of reduced dosage when administering fibrinolytics to patients aged 75 years and older </li>
    <li>Transfer to a percutaneous coronary intervention (PCI)-capable hospital </li>
    <li>Use of clinical judgment when deciding to provide or withhold morphine in patients undergoing reperfusion therapy </li>
</ol>"/>
    </field>
    <field fieldid="134" ordby="440" id="404" name="Major Outcomes Considered" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>Incidence of major adverse cardiac events (MACE) </li>
    <li>Mortality </li>
    <li>Myocardial infarction (MI), stroke, and revascularization </li>
    <li>Adverse effects of opioids </li>
</ul>"/>
    </field>
  </section>
  <section secid="405" ordby="500" name="Methodology">
    <field fieldid="109" ordby="505" id="406" name="Methods Used to Collect/Select the Evidence" type="picklist-many">
      <fieldvalue value="Hand-searches of Published Literature (Primary Sources)"/>
      <fieldvalue value="Hand-searches of Published Literature (Secondary Sources)"/>
      <fieldvalue value="Searches of Electronic Databases"/>
    </field>
    <field fieldid="135" ordby="510" id="407" name="Description of Methods Used to Collect/Select the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This clinical policy is based on a systematic review with critical analysis of the medical literature meeting the inclusion criteria. Searches of MEDLINE, MEDLINE InProcess, Cochrane, EMBASE, and Scopus databases were performed. All searches were limited to human studies published in English. Specific key words/phrases, years used in the searches, dates of searches, and study selection are identified under each critical question in the original guideline document. In addition, relevant articles from the bibliographies of included studies and more recent articles identified by committee members and reviewers were included.</p></div>"/>
    </field>
    <field fieldid="136" ordby="515" id="408" name="Number of Source Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Study Selection</span></strong></p>
<p><strong>Critical Question 1</strong></p>
<p>Two hundred thirty-four articles were identified in the search. Forty-three articles were selected from the search results for further review, with 6 Class III studies included for this critical question.</p>
<p><strong>Critical Question 2</strong></p>
<p>Two hundred two articles were identified in the search. Forty-five articles were selected from the search results for further review, with 1 Class II and 1 Class III study included for this critical question.</p>
<p><strong>Critical Question 3</strong></p>
<p>Twenty-five articles were identified in the search. Nine articles were selected from the search results for further review, with 1 Class III study included for this critical question.</p></div>"/>
    </field>
    <field fieldid="115" ordby="520" id="409" name="Methods Used to Assess the Quality and Strength of the Evidence" type="picklist-choice">
      <fieldvalue value="Weighting According to a Rating Scheme (Scheme Given)"/>
    </field>
    <field fieldid="149" ordby="525" id="410" name="Rating Scheme for the Strength of the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Strength of Evidence</span></strong></p>
<p><strong>Literature Classification Schema*</strong></p>
<table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Literature Classification Schema&quot;>
    <thead>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Design/Class</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Therapy&amp;dagger;</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Diagnosis&amp;Dagger;</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>Prognosis&amp;sect;</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>1</td>
            <td valign=&quot;top&quot;>Randomized controlled trial or meta-analysis of randomized trials</td>
            <td valign=&quot;top&quot;>Prospective cohort using a criterion standard or meta-analysis of prospective studies</td>
            <td valign=&quot;top&quot;>Population prospective cohort or meta-analysis of prospective studies</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>2</td>
            <td valign=&quot;top&quot;>Nonrandomized trial</td>
            <td valign=&quot;top&quot;>Retrospective observational</td>
            <td valign=&quot;top&quot;>Retrospective cohort<br />
            Case control </td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>3</td>
            <td valign=&quot;top&quot;>Case series</td>
            <td valign=&quot;top&quot;>Case series</td>
            <td valign=&quot;top&quot;>Case series</td>
        </tr>
    </tbody>
</table>
<p class=&quot;Note&quot;>*Some designs (e.g., surveys) will not fit this schema and should be assessed individually.</p>
<p class=&quot;Note&quot;><sup>&amp;dagger;</sup>Objective is to measure therapeutic efficacy comparing interventions.</p>
<p class=&quot;Note&quot;><sup>&amp;Dagger;</sup>Objective is to determine the sensitivity and specificity of diagnostic tests.</p>
<p class=&quot;Note&quot;><sup>&amp;sect;</sup>Objective is to predict outcome, including mortality and morbidity.</p>
<p><strong>Approach to Downgrading Strength of Evidence*</strong> </p>
<table width=&quot;60%&quot; border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Approach to Downgrading Strength of Evidence&quot;>
    <thead>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; rowspan=&quot;2&quot; scope=&quot;col&quot;>Downgrading</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;3&quot; scope=&quot;col&quot;>Design/Class</th>
        </tr>
        <tr>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>1</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>2</th>
            <th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;>3</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign=&quot;top&quot;>None</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>I</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>II</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>III</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>1 level</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>II</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>III</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>2 levels</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>III</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Fatally flawed</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>X</td>
        </tr>
    </tbody>
</table>
<p class=&quot;Note&quot;>*See the &quot;Description of Methods Used to Analyze the Evidence&quot; field for more information.</p></div>"/>
    </field>
    <field fieldid="116" ordby="530" id="411" name="Methods Used to Analyze the Evidence" type="picklist-many">
      <fieldvalue value="Systematic Review with Evidence Tables"/>
    </field>
    <field fieldid="150" ordby="535" id="412" name="Description of the Methods Used to Analyze the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Assessment of Classes of Evidence</span></strong></p>
<p>Two methodologists independently graded and assigned a preliminary Class of Evidence for all articles used in the formulation of this clinical policy. Class of Evidence is delineated whereby an article with design 1 represents the strongest study design and subsequent design classes (i.e., design 2 and design 3) represent respectively weaker study designs for therapeutic, diagnostic, or prognostic studies, or meta-analyses (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field). Articles are then graded on dimensions related to the study's methodological features, such as randomization processes, blinding, allocation concealment, methods of data collection, outcome measures and their assessment, selection and misclassification biases, sample size, generalizability, data management, analyses, congruence of results and conclusions, and conflicts of interest. Using a predetermined process combining the study's design, methodological quality, and applicability to the critical question, articles received a Class of Evidence grade. An adjudication process involving discussion with the original methodologist graders and at least one additional methodologist was then used to address any discordance in original grading, resulting in a final Class of Evidence assignment (i.e., Class I, Class II, Class III, or Class X) (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field). Articles identified with fatal flaws or ultimately determined to not be applicable to the critical question received a Class of Evidence grade &quot;X&quot; and were not used in formulating recommendations for this policy. However, content in these articles may have been used to formulate the background and to inform expert consensus in the absence of robust evidence. Grading was done with respect to the specific critical questions; thus, the Class of Evidence for any one study may vary according to the question for which it is being considered. As such, it was possible for a single article to receive a different Class of Evidence rating when addressing a different critical question. Question-specific Classes of Evidence grading may be found in the Evidentiary Table in the original guideline document.</p></div>"/>
    </field>
    <field fieldid="112" ordby="540" id="413" name="Methods Used to Formulate the Recommendations" type="picklist-choice">
      <fieldvalue value="Expert Consensus"/>
    </field>
    <field fieldid="145" ordby="545" id="414" name="Description of Methods Used to Formulate the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This policy is a product of the American College of Emergency Physicians (ACEP) clinical policy development process, including internal and external review, and is based on the existing literature; when literature was not available, consensus of Clinical Policies Committee members was used and noted as such in the recommendation (i.e., consensus recommendation).</p>
<p>When possible, clinically oriented statistics (e.g., likelihood ratios, number needed to treat) are presented to help the reader better understand how the results may be applied to the individual patient. For a definition of these statistical concepts, see Appendix C in the original guideline document.</p></div>"/>
    </field>
    <field fieldid="146" ordby="550" id="415" name="Rating Scheme for the Strength of the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Translation of Class of Evidence to Recommendation Levels</span></strong></p>
<p>Based on the strength of evidence grading for each critical question (see the Evidentiary Table in the original guideline document), the subcommittee drafted the recommendations and the supporting text synthesizing the evidence using the following guidelines:</p>
<p><strong>Level A recommendations</strong>. Generally accepted principles for patient care that reﬂect a high degree of clinical certainty (e.g., based on evidence from 1 or more Class of Evidence I or multiple Class of Evidence II studies).</p>
<p><strong>Level B recommendations</strong>. Recommendations for patient care that may identify a particular strategy or range of strategies that reﬂect moderate clinical certainty (e.g., based on evidence from 1 or more Class of Evidence II studies or strong consensus of Class of Evidence III studies).</p>
<p><strong>Level C recommendations</strong>. Recommendations for patient care that are based on evidence from Class of Evidence III studies or, in the absence of any adequate published literature, based on expert consensus. In instances in which consensus recommendations are made, &quot;consensus&quot; is placed in parentheses at the end of the recommendation.</p>
<p>There are certain circumstances in which the recommendations stemming from a body of evidence should not be rated as highly as the individual studies on which they are based. Factors such as heterogeneity of results, uncertainty about effect magnitude and publication bias, among others, might lead to such a downgrading of recommendations.</p></div>"/>
    </field>
    <field fieldid="148" ordby="565" id="417" name="Cost Analysis" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div>"/>
    </field>
    <field fieldid="104" ordby="570" id="418" name="Method of Guideline Validation" type="picklist-choice">
      <fieldvalue value="External Peer Review"/>
      <fieldvalue value="Internal Peer Review"/>
    </field>
    <field fieldid="130" ordby="575" id="419" name="Description of Method of Guideline Validation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Review comments were received from emergency physicians, cardiologists, individual members of the American College of Cardiology Foundation/American Heart Association, a patient representative, and members of American College of Emergency Physicians' (ACEP's) Medical-Legal Committee. Comments were received during a 60-day open-comment period, with notices of the comment period sent in an e-mail to ACEP members, published in <em>EM Today</em>, and posted on the ACEP Web site. The responses were used to further refine and enhance this clinical policy; however, responses do not imply endorsement.</p>
<p>This clinical policy was approved by the ACEP Board of Directors on June 28, 2017.</p>
<p>This guideline was endorsed by the Emergency Nurses Association on August 22, 2017.</p></div>"/>
    </field>
  </section>
  <section secid="424" ordby="600" name="Evidence Supporting the Recommendations">
    <field fieldid="139" ordby="610" id="426" name="Type of Evidence Supporting the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The type of supporting evidence is identified and graded for each recommendation (see the &quot;Major Recommendations&quot; field).</p>
<p>Recommendations for question 1 were based on 6 Class III studies. Recommendations for question 2 were based on 1 Class II and 1 Class III studies. Recommendations for questions 3 were based on 1 Class III study.</p></div>"/>
    </field>
  </section>
  <section secid="427" ordby="700" name="Benefits/Harms of Implementing the Guideline Recommendations">
    <field fieldid="152" ordby="705" id="428" name="Potential Benefits" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>The use of fibrinolytics when door-to-balloon (D2B) time is delayed may result in better long-term outcomes with a decrease in major adverse cardiac events (MACE). </li>
    <li>Patients who receive timely percutaneous coronary intervention (PCI) may experience better outcomes with a decrease in MACE. </li>
    <li>Opioids offer relief to chest pain patients by reducing discomfort and helping them relax during a highly stressful medical event. </li>
</ul>"/>
    </field>
    <field fieldid="153" ordby="710" id="429" name="Potential Harms" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>Time estimates are challenging to obtain in the context of an emergency, therefore patients may not receive the recommended therapy within the appropriate time frame necessary to achieve optimal outcomes. </li>
    <li>Patients may decompensate en route to the percutaneous coronary intervention (PCI) facility resulting in poor outcomes. </li>
    <li>Opioids can potentially result in less salvageable myocardium if administered to patients having a myocardial infarction (MI). </li>
</ul>"/>
    </field>
  </section>
  <section secid="432" ordby="900" name="Qualifying Statements">
    <field fieldid="137" ordby="905" id="433" name="Qualifying Statements" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>Policy statements and clinical policies are the official policies of the American College of Emergency Physicians (ACEP) and, as such, are not subject to the same peer review process as articles appearing in the journal. Policy statements and clinical policies of ACEP do not necessarily reflect the policies and beliefs of <em>Annals of Emergency Medicine</em> and its editors. </li>
    <li>This policy is not intended to be a complete manual on the evaluation and management of patients with ST-segment elevation myocardial infarction (STEMI) but rather a focused examination of critical issues that have particular relevance to the current practice of emergency medicine. </li>
    <li>It is the goal of the Clinical Policies Committee to provide an evidence-based recommendation when the medical literature provides enough quality information to answer a critical question. When the medical literature does not contain adequate empirical data to answer a critical question, the members of the Clinical Policies Committee believe that it is equally important to alert emergency physicians to this fact. </li>
    <li>This clinical policy is not intended to represent a legal standard of care for emergency physicians. Recommendations offered in this policy are not intended to represent the only diagnostic or management options available to the emergency physician. ACEP recognizes the importance of the individual physician's judgment and patient preferences. This guideline provides clinical strategies for which medical literature exists to answer the critical questions addressed in this policy. </li>
</ul>"/>
    </field>
  </section>
  <section secid="434" ordby="1000" name="Implementation of the Guideline">
    <field fieldid="131" ordby="1010" id="436" name="Description of Implementation Strategy" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>An implementation strategy was not provided.</p></div>"/>
    </field>
    <field fieldid="117" ordby="1015" id="437" name="Implementation Tools" type="picklist-many">
      <fieldvalue value="Mobile Device Resources"/>
    </field>
  </section>
  <section secid="439" ordby="1100" name="Institute of Medicine (IOM) National Healthcare Quality Report Categories">
    <field fieldid="50" ordby="1105" id="440" name="IOM Care Need" type="picklist-many">
      <fieldvalue value="Getting Better"/>
    </field>
    <field fieldid="51" ordby="1110" id="441" name="IOM Domain" type="picklist-many">
      <fieldvalue value="Effectiveness"/>
      <fieldvalue value="Timeliness "/>
    </field>
  </section>
  <section secid="442" ordby="1200" name="Identifying Information and Availability">
    <field fieldid="97" ordby="1201" id="392" name="Bibliographic Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>Promes SB, Glauser JM, Smith MD, Torbati SS, Brown MD, American College of Emergency Physicians. Clinical policy: emergency department management of patients needing reperfusion therapy for acute ST-segment elevation myocardial infarction. Ann Emerg Med. 2017 Nov;70(5):724-39. [28 references] <a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=29056206 &quot; target=&quot;_blank&quot;>PubMed</a></td></tr></table>"/>
    </field>
    <field fieldid="124" ordby="1205" id="443" name="Adaptation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Not applicable: The guideline was not adapted from another source.</p></div>"/>
    </field>
    <field fieldid="128" ordby="1215" id="445" name="Date Released" type="text">
      <fieldvalue value="2017 Nov"/>
    </field>
    <field fieldid="158" ordby="1225" id="447" name="Guideline Developer(s)" type="orglist-p">
      <fieldvalue value="American College of Emergency Physicians - Medical Specialty Society"/>
    </field>
    <field fieldid="125" ordby="1235" id="449" name="Source(s) of Funding" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The American College of Emergency Physicians was the funding source for this clinical policy.</p></div>"/>
    </field>
    <field fieldid="126" ordby="1240" id="450" name="Guideline Committee" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>American College of Emergency Physicians (ACEP) Clinical Policies Subcommittee (Writing Committee) on Reperfusion Therapy for Acute ST-Segment Elevation Myocardial Infarction</p>
<p>ACEP Clinical Policies Committee (Oversight Committee)</p></div>"/>
    </field>
    <field fieldid="127" ordby="1245" id="451" name="Composition of Group That Authored the Guideline" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><em>Members of the Subcommittee (Writing Committee) on Reperfusion Therapy for Acute ST-Segment Elevation Myocardial Infarction</em>: Susan B. Promes, MD, MBA (<em>Subcommittee Chair</em>); Jonathan M. Glauser, MD, MBA; Michael D. Smith, MD, MBA; Sam S. Torbati, MD; Michael D. Brown, MD, MSc (<em>Committee Chair</em>)</p>
<p><em>Members of the Clinical Policies Committee (Oversight Committee)</em>: Michael D. Brown, MD, MSc (<em>Chair 2014-2017</em>); Richard Byyny, MD, MSc (<em>Methodologist</em>); Deborah B. Diercks, MD, MSc; Seth R. Gemme, MD; Charles J. Gerardo, MD, MHS; Steven A. Godwin, MD; Sigrid A. Hahn, MD, MPH; Benjamin W. Hatten, MD, MPH; Jason S. Haukoos, MD, MSc (<em>Methodologist</em>); Graham S. Ingalsbe, MD (<em>EMRA Representative 2015-2017</em>); Amy Kaji, MD, MPH, PhD (<em>Methodologist</em>); Heemun Kwok, MD, MS (<em>Methodologist</em>); Bruce M. Lo, MD, MBA, RDMS; Sharon E. Mace, MD; Devorah J. Nazarian, MD; Jean A. Proehl, RN, MN, CEN, CPEN (<em>ENA Representative 2015-2017</em>); Susan B. Promes, MD, MBA; Kaushal H. Shah, MD; Richard D. Shih, MD; Scott M. Silvers, MD; Michael D. Smith, MD, MBA; Molly E. W. Thiessen, MD; Christian A. Tomaszewski, MD, MS, MBA; Jonathan H. Valente, MD; Stephen P. Wall, MD, MSc, MAEd (<em>Methodologist</em>); Stephen J. Wolf, MD; Stephen V. Cantrill, MD (<em>Liaison with Quality and Patient Safety Committee</em>); Jon Mark Hirshon, MD, MPH, PhD (<em>Board Liaison 2016-2017</em>); Rhonda R. Whitson, RHIA, Staff Liaison, Clinical Policies Committee and Subcommittee Revising the Reperfusion Therapy for Acute Myocardial Infarction Clinical Policy; Travis Schulz, MLS, AHIP, Staff Liaison, Clinical Policies Committee</p></div>"/>
    </field>
    <field fieldid="147" ordby="1250" id="452" name="Financial Disclosures/Conflicts of Interest" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Relevant industry relationships: There were no relevant industry relationships disclosed by the subcommittee members for this topic.</p>
<p>Relevant industry relationships are those relationships with companies associated with products or services that significantly impact the specific aspect of disease addressed in the critical question.</p></div>"/>
    </field>
    <field fieldid="159" ordby="1255" id="453" name="Guideline Endorser(s)" type="orglist">
      <fieldvalue value="Emergency Nurses Association - Professional Association"/>
    </field>
    <field fieldid="120" ordby="1256" id="393" name="Guideline Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Fesmire FM, Brady WJ, Hahn S, Decker WW, Diercks DB, Ghaemmaghami CA, Nazarian D, Jagoda AS, American College of Emergency Physicians Clinical Policies Subcommittee. Clinical policy: indications for reperfusion therapy in emergency department patients with suspected acute myocardial infarction. Ann Emerg Med. 2006 Oct;48(4):358-83. [86 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div>"/>
    </field>
    <field fieldid="118" ordby="1260" id="454" name="Guideline Availability" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Available from the <a href=&quot;http://www.annemergmed.com/article/S0196-0644%2817%2931743-2/pdf&quot; title=&quot;American College of Emergency Physicians (ACEP) Web site&quot;>American College of Emergency Physicians (ACEP) Web site</a>.</p>
<p>A summary of this guideline optimized for mobile viewing is available under the CQ tab at the<a href=&quot;https://www.acep.org/Clinical---Practice-Management/ACEP-Current-Clinical-Policies/#sm.001hivb7weiqfl911io1auwgwnvk7&quot; title=&quot;ACEP Web site&quot;> ACEP Web site</a>.</p></div>"/>
    </field>
    <field fieldid="119" ordby="1265" id="455" name="Availability of Companion Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The following are available:</p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>American College of Emergency Physicians clinical policy development. Irving (TX): American College of Emergency Physicians (ACEP). 3 p. Available from the <a href=&quot;https://www.acep.org/Clinical---Practice-Management/ACEP-Clinical-Policy-Development/&quot; title=&quot;American College of Emergency Physicians (ACEP) Web site&quot;>American College of Emergency Physicians (ACEP) Web site</a>. </li>
    <li>ACEP clinical policy development process. Flow chart. Irving (TX): American College of Emergency Physicians (ACEP). 1 p. Available from the <a href=&quot;https://www.acep.org/Clinical---Practice-Management/ACEP-Clinical-Policy-Development-Process/&quot; title=&quot;ACEP Web site&quot;>ACEP Web site</a>. </li>
</ul></div>"/>
    </field>
    <field fieldid="143" ordby="1275" id="457" name="Patient Resources" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>None available</p></div>"/>
    </field>
    <field fieldid="142" ordby="1280" id="458" name="NGC Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This NGC summary was completed by ECRI on November 29, 2006. The information was verified by the guideline developer on March 12, 2007. The summary was updated by ECRI Institute on January 29, 2018. The updated information was verified by the guideline developer on March 5, 2018.</p>
<p>This NEATS assessment was completed by ECRI Institute on February 1, 2018. The information was verified by the guideline developer on March 5, 2018.</p></div>"/>
    </field>
    <field fieldid="141" ordby="1290" id="460" name="Copyright Statement" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. For more information, please refer to the <a href=&quot;http://www.acep.org/aboutus.aspx?id=30296&quot; title=&quot;American College of Emergency Physicians (ACEP) Web site&quot;>American College of Emergency Physicians (ACEP) Web site</a>.</p></div>"/>
    </field>
  </section>
  <section secid="99999" ordby="99999" name="Disclaimer">
    <field fieldid="99999" ordby="99999" id="99999" name="NGC Disclaimer" type="text">
      <fieldvalue value="<p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;>NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p>"/>
    </field>
  </section>
</version><!--
     FILE ARCHIVED ON 19:42:56 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 16:57:20 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 221.283 (3)
  esindex: 0.008
  captures_list: 244.19
  CDXLines.iter: 13.82 (3)
  PetaboxLoader3.datanode: 43.858 (4)
  exclusion.robots: 0.278
  exclusion.robots.policy: 0.267
  RedisCDXSource: 5.779
  PetaboxLoader3.resolve: 413.55 (4)
  load_resource: 257.868
-->